FDA Approves AI-Powered Handheld Device to Help Doctors Diagnose Skin Cancer
-
FDA approves new AI-powered handheld device by DermaSensor that helps doctors diagnose skin cancer by analyzing skin lesions.
-
Device beams light at skin and detects differences in light reflection patterns between healthy and cancerous skin cells.
-
In studies, device had 96% sensitivity and 97% specificity for detecting skin cancer; halved missed case rate from 18% to 9%.
-
Can detect various skin cancer types like melanoma; aims to help primary care doctors catch disease earlier.
-
Costs $199/month for up to 5 patients or $399/month for unlimited users and scans.